Ibex Technologies (TSXV:IBT) Days Sales Outstanding : 61.17 (As of Jan. 2024)

View and export this data going back to 1986. Start your Free Trial

What is Ibex Technologies Days Sales Outstanding?

Ibex Technologies's average Accounts Receivable for the three months ended in Jan. 2024 was C$1.29 Mil. Ibex Technologies's Revenue for the three months ended in Jan. 2024 was C$1.92 Mil. Hence, Ibex Technologies's Days Sales Outstanding for the three months ended in Jan. 2024 was 61.17.

The historical rank and industry rank for Ibex Technologies's Days Sales Outstanding or its related term are showing as below:

TSXV:IBT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 29.5 Med: 48.77 Max: 64.26
Current: 53.87

During the past 13 years, Ibex Technologies's highest Days Sales Outstanding was 64.26. The lowest was 29.50. And the median was 48.77.

TSXV:IBT's Days Sales Outstanding is ranked better than
65.91% of 886 companies
in the Biotechnology industry
Industry Median: 72.34 vs TSXV:IBT: 53.87

Ibex Technologies's Days Sales Outstanding increased from Jan. 2023 (48.04) to Jan. 2024 (61.17).

Ibex Technologies Days Sales Outstanding Historical Data

The historical data trend for Ibex Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibex Technologies Days Sales Outstanding Chart

Ibex Technologies Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Days Sales Outstanding

Get a 7-Day Free Trial

64.26

55.35

56.20

40.61

43.14

Ibex Technologies Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Days Sales Outstanding	Get a 7-Day Free Trial															48.04	48.83	64.28	53.58	61.17

Competitive Comparison of Ibex Technologies's Days Sales Outstanding

For the Biotechnology subindustry, Ibex Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ibex Technologies's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ibex Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Ibex Technologies's Days Sales Outstanding falls into.

Ibex Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Ibex Technologies's Days Sales Outstanding for the fiscal year that ended in Jul. 2023 is calculated as

	Days Sales Outstanding (A: Jul. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jul. 2022 )	+	Accounts Receivable (A: Jul. 2023 ))	/	count )	/	Revenue (A: Jul. 2023 )	*	Days in Period
=	( (0.869	+	0.902)	/	2 )	/	7.492	*	365
=	0.8855					/	7.492	*	365
=	43.14

Ibex Technologies's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

	Days Sales Outstanding (Q: Jan. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Oct. 2023 )	+	Accounts Receivable (A: Jan. 2024 ))	/	count )	/	Revenue (A: Jan. 2024 )	*	Days in Period
=	( (1.515	+	1.062)	/	2 )	/	1.922	*	365 / 4
=	1.2885					/	1.922	*	365 / 4
=	61.17

Ibex Technologies (TSXV:IBT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Ibex Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Ibex Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Ibex Technologies (TSXV:IBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (TSXV:IBT) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

IBXNF:USA IBT:Germany

Address

5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7

Website

https://www.ibex.ca

Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (TSXV:IBT) Headlines

No Headlines